The effect of Keishibukuryogan on uterine subinvolution after child birth

The effect of Keishibukuryogan on uterine subinvolution after child birth - The effct of Keishibukuryogan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220407

Enrollment

100

Registered

2019-01-25

Start date

2019-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine subinvolution after child birth

Interventions

Intervention type:DRUG Name of intervention:Administration group of Keishibukuryogan Dose form / Japanese Medical Device Nomenclature:GRANULES Route of administration / Site of application:ORAL Dose p

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: postpurtum women who gave birth at Ukita Clinic

Exclusion criteria

Exclusion criteria: Caesarean section,severe anemia,atonic bleeding(>500ml),hypertensive disorders of pregnancy,gestational diabetes,uterine myoma,endmetriosis

Design outcomes

Primary

Measure	Time frame
existence of subinvolution or not	—

Secondary

Measure	Time frame
prosperities of locia, dose of brest milk, the intensity of post-labor pains	—

Countries

Japan

Contacts

Public ContactShingo Ukita

Medical corporation Seseragi Ukita clinic

shingo@ukita.gr.jp+81-77-574-3751

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026